Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information.
Osborn
John E
JE
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D000068258:Bevacizumab; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D006801:Humans; D007880:Legislation, Drug / Q000941:ethics / Q000639:trends; D000077408:Modafinil; D009465:Neuromuscular Agents / Q000627:therapeutic use; D056687:Off-Label Use / Q000941:ethics / Q000331:legislation & jurisprudence; D063065:Organophosphonates / Q000627:therapeutic use; D011050:Policy Making; D011640:Public Policy / Q000331:legislation & jurisprudence / Q000639:trends; D000069579:Ranibizumab; D000068698:Tenofovir; D016896:Treatment Outcome; D014342:Truth Disclosure; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D020533:Angiogenesis Inhibitors; D019380:Anti-HIV Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D009465:Neuromuscular Agents; D063065:Organophosphonates; D000068258:Bevacizumab; D000068698:Tenofovir; D019274:Botulinum Toxins, Type A; D000225:Adenine; D000077408:Modafinil; D000069579:Ranibizumab